0009-0001-8262-9237 About
I am currently pursuing a Ph.D. in Pharmaceutical Analysis, with a research focus on impurity profiling, genotoxic impurities, and LC–MS/MS-based quantification methods. My work primarily involves the development and validation of analytical methods for detecting nitrosamine impurities (such as NDMA and NDEA) in pharmaceutical APIs and formulations.
I have over three years of industrial experience in Analytical R&D at Strides Pharma Pvt. Ltd., where I was involved in method development, validation, and stability studies for regulatory submissions. My academic and industrial background together support my interest in analytical toxicology, degradation pathway elucidation, and regulatory sciences.
My current research integrates chromatographic and mass spectrometric techniques to ensure the safety, efficacy, and quality of drug products in compliance with global regulatory guidelines (ICH,) USFDA, EMA).
Employment
-
JSS College of pharmacy Research Scholar2022 - 2026
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (6)
- A VALIDATED ANALYTICAL METHOD FOR RANITIDINE HCL THROUGH LC-MS/MS, HPLC AND QUALITY BY DESIGN APPROACH. Save
- NATURAL CYSTEINE PROTEASES IN FOCUS: BIOMEDICAL AND INDUSTRIAL PERSPECTIVES OF PAPAIN, BROMELAIN, AND FICIN Save
- Development and Validation of a Robust Analytical Method for the Quantification of NDMA and NDEA Impurities in Ranitidine Hydrochloride API by HPLC and LC-MS/MS Save
- Genotoxic Impurity for Degradation Products: The Review Save
- A Review on N-nitrosamine Impurity Save
- A Validated Analytical Method for Dacomitinib (Anti-Cancer Drug) Through Lc-Ms/Ms, Hplc & Quality by Design Approach Save